Ong S, Daneman N, Davis J, Tong S
Open Forum Infect Dis. 2025; 12(2):ofaf063.
PMID: 39963704
PMC: 11832037.
DOI: 10.1093/ofid/ofaf063.
Hendriks M, Schweren K, Kleij A, Berrevoets M, de Jong E, van Wijngaarden P
Clin Infect Dis. 2024; 79(1):43-51.
PMID: 38576380
PMC: 11259217.
DOI: 10.1093/cid/ciae187.
Kouijzer I, Fowler Jr V, Ten Oever J
J Infect. 2022; 86(1):9-13.
PMID: 36370898
PMC: 11105116.
DOI: 10.1016/j.jinf.2022.10.042.
Hamad Y, Connor L, Bailey T, George I
Open Forum Infect Dis. 2020; 7(9):ofaa341.
PMID: 32908944
PMC: 7470468.
DOI: 10.1093/ofid/ofaa341.
Dagher M, Fowler Jr V, Wright P, Staub M
Open Forum Infect Dis. 2020; 7(6):ofaa151.
PMID: 32523971
PMC: 7270708.
DOI: 10.1093/ofid/ofaa151.
The updated Charlson comorbidity index is a useful predictor of mortality in patients with Staphylococcus aureus bacteraemia.
Ternavasio-de la Vega H, Castano-Romero F, Ragozzino S, Sanchez Gonzalez R, Vaquero-Herrero M, Siller-Ruiz M
Epidemiol Infect. 2018; 146(16):2122-2130.
PMID: 30173679
PMC: 6453015.
DOI: 10.1017/S0950268818002480.
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial.
Thwaites G, Scarborough M, Szubert A, Nsutebu E, Tilley R, Greig J
Lancet. 2017; 391(10121):668-678.
PMID: 29249276
PMC: 5820409.
DOI: 10.1016/S0140-6736(17)32456-X.
Once-Daily Treatments for Methicillin-Susceptible Staphylococcus aureus Bacteremia: Are They Good Enough?.
Lother S, Press N
Curr Infect Dis Rep. 2017; 19(11):43.
PMID: 28942574
DOI: 10.1007/s11908-017-0599-0.
Cefazolin versus Nafcillin for Methicillin-Sensitive Staphylococcus aureus Bloodstream Infection in a California Tertiary Medical Center.
Pollett S, Baxi S, Rutherford G, Doernberg S, Bacchetti P, Chambers H
Antimicrob Agents Chemother. 2016; 60(8):4684-9.
PMID: 27216053
PMC: 4958157.
DOI: 10.1128/AAC.00243-16.
Improving the management of Staphylococcus aureus bacteraemia, including MRSA.
Meyer C, Pett E
BMJ Qual Improv Rep. 2016; 2(1).
PMID: 26734194
PMC: 4652725.
DOI: 10.1136/bmjquality.u201154.w908.
Simplified risk stratification criteria for identification of patients with MRSA bacteremia at low risk of infective endocarditis: implications for avoiding routine transesophageal echocardiography in MRSA bacteremia.
Buitron de la Vega P, Tandon P, Qureshi W, Nasr Y, Jayaprakash R, Arshad S
Eur J Clin Microbiol Infect Dis. 2015; 35(2):261-8.
PMID: 26676855
PMC: 4724372.
DOI: 10.1007/s10096-015-2539-y.
Ceftaroline Fosamil for the Treatment of Bacteremia Secondary to Acute Bacterial Skin and Skin Structure Infections or Community-Acquired Bacterial Pneumonia.
Vazquez J, Maggiore C, Cole P, Smith A, Jandourek A, Friedland H
Infect Dis Clin Pract (Baltim Md). 2015; 23(1):39-43.
PMID: 25574117
PMC: 4280277.
DOI: 10.1097/IPC.0000000000000191.
Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting.
Youngster I, Shenoy E, Hooper D, Nelson S
Clin Infect Dis. 2014; 59(3):369-75.
PMID: 24785233
PMC: 4110443.
DOI: 10.1093/cid/ciu301.
The complex pathogenesis of bacteremia: from antimicrobial clearance mechanisms to the genetic background of the host.
Christaki E, Giamarellos-Bourboulis E
Virulence. 2013; 5(1):57-65.
PMID: 24067507
PMC: 3916384.
DOI: 10.4161/viru.26514.
Treatment duration for uncomplicated Staphylococcus aureus bacteremia to prevent relapse: analysis of a prospective observational cohort study.
Chong Y, Moon S, Bang K, Park H, Park S, Kim M
Antimicrob Agents Chemother. 2012; 57(3):1150-6.
PMID: 23254436
PMC: 3591920.
DOI: 10.1128/AAC.01021-12.
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial.
Thwaites G, Auckland C, Barlow G, Cunningham R, Davies G, Edgeworth J
Trials. 2012; 13:241.
PMID: 23249501
PMC: 3557210.
DOI: 10.1186/1745-6215-13-241.
Predictors of mortality in Staphylococcus aureus Bacteremia.
Van Hal S, Jensen S, Vaska V, Espedido B, Paterson D, Gosbell I
Clin Microbiol Rev. 2012; 25(2):362-86.
PMID: 22491776
PMC: 3346297.
DOI: 10.1128/CMR.05022-11.
Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography.
Rasmussen R, Host U, Arpi M, Hassager C, Johansen H, Korup E
Eur J Echocardiogr. 2011; 12(6):414-20.
PMID: 21685200
PMC: 3117467.
DOI: 10.1093/ejechocard/jer023.
The management of Staphylococcus aureus bacteremia in the United Kingdom and Vietnam: a multi-centre evaluation.
Thwaites G
PLoS One. 2010; 5(12):e14170.
PMID: 21179193
PMC: 3001442.
DOI: 10.1371/journal.pone.0014170.